Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer

BACKGROUND: The choice of anticoagulant agent for patients with nonvalvular atrial fibrillation (NVAF) in the setting of active cancer has not been well studied. OBJECTIVES: The aim of this study was to compare the rates of cerebrovascular accident (CVA), gastrointestinal bleeding (GIB), and intracr...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, Adam S., Patel, Ashley, Khawaja, Muzamil, Chen, Christopher, Zheng, Henry, Kaczmarek, Jessica, Gao, Feng, Karimzad, Kaveh, Song, Juhee, Koutroumpakis, Efstratios, Khalaf, Shaden, Iliescu, Cezar, Deswal, Anita, Palaskas, Nicolas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537073/
https://www.ncbi.nlm.nih.gov/pubmed/36213361
http://dx.doi.org/10.1016/j.jaccao.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537073/
https://www.ncbi.nlm.nih.gov/pubmed/36213361
http://dx.doi.org/10.1016/j.jaccao.2022.07.004

Ejemplares similares